Skip to main content
Premium Trial:

Request an Annual Quote

IPOs Abound...Sort Of

Yesterday's Wall Street Journal included a feature article on the comeback of technology IPOs. (Thank goodness. We needed the refresher course after almost forgetting what "IPO" stood for.)

IPOs seem to be making a comeback in this field as well. Rosetta Genomics recently raised more than $25 million in its first offering, and Helicos BioSciences filed for an IPO of its own at the end of February.

 

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.